3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Status
Terminated
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Conditions
Glioblastoma
4
Small Cell Lung Carcinoma
2
Breast Neoplasms
2
Pancreatic Neoplasms
1
Pancreatic Cancer Metastatic
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Gliosarcoma
1
Glioma
1
Chondrosarcoma
1
Cholangiocarcinoma
1
Carcinoma, Intraductal, Noninfiltrating
1
Brain Neoplasms
1
Interventions
Etoposide
79
Carboplatin
67
Cisplatin
58
durvalumab
29
Irinotecan
29
Radiotherapy
27
atezolizumab
23
Topotecan
21
anlotinib
19
Nivolumab
15
Drug Therapy
15
Radiosurgery
14
Gemcitabine
13
apatinib
12
Paclitaxel
12
toripalimab
10
Platinum
10
Docetaxel
10
tislelizumab
9
Temozolomide
9
PM 01183
8
pembrolizumab
7
olaparib
7
Magnetic Resonance Spectroscopy
7
Ipilimumab
7
Bevacizumab
7
Albumin-Bound Paclitaxel
7
irinotecan sucrosofate
6
Counseling
6
sintilimab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Small Cell Lung Carcinoma
×
Chloroquine
×
Clear all
NCT00969306
2019-02-15
Chloroquine IV
Maastricht Radiation Oncology
Phase 1
Terminated
5 enrolled
NCT01575782
2017-07-18
Chloroquine
Maastricht Radiation Oncology
Phase 1
Terminated
5 enrolled